UNIVERSITY OF UTAH



ZHENG-RONG LU

M. Frank Rudy and Margaret Domiter Rudy Professor of Biomedical Engineering

Case Western Reserve University

Department OF Biomedical Engineering

Wickenden Building Room 427

10900 Euclid Avenue

Cleveland, Ohio 44106-7207

Phone: (216) 368-0187 (Office)

FAX: (216) 368-4969

E-mail: zxl125@case.edu

EDUCATION

1980 -1987 Department of Chemistry, Lanzhou University, Lanzhou, China

B.Sc. in 1984 and M.Sc. (Organic Chemistry) in 1987

1987-1990 Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, China

Ph.D. (Physical Chemistry) in 1991

1990-1992 Postdoctoral Fellow, Department of Chemistry, Wuhan University, China

1996-1998 Postdoctoral Fellow, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah

APPOINTMENTS AND RESEARCH ACTIVITies

1992-1993 Associate Professor of Chemistry, Department of Chemistry, Wuhan

University, Wuhan, China

1993-1996 Professor of Chemistry, Laboratory of Biomedical Polymers of the Ministry of Education of China, Department of Chemistry, Wuhan University, China

Nov. 1994-

Jun. 1995 Visiting Scientist, at School of Chemistry and Molecular Science, University of Sussex at Brighton, UK

Jul. 1995-

Oct. 1995 Visiting Scientist, at the Centre of Polymer Therapeutics, School of Pharmacy, University of London, UK.

1998 –

July 1999 Research Associate, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah

July 1999-

2001 Research Assistant Professor, Department of Pharmaceutics and Pharmaceutical Chemistry/CCCD, University of Utah

Jan. 2002-

June 2006 Assistant Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah

Aug. 2002-

present Adjunct Assistant Professor, Department of Radiology, University of Utah

2003-present Cancer Center Member, Huntsman Cancer Institute, University of Utah

2004-present Adjunct Assistant Professor, Department of Materials Science and Engineering, University of Utah

July 2006 –

April 2009 Associate Professor with tenure, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah

May 2009 – Professor, Department of Biomedical Engineering, Case Western Reserve University

AWARD and Honors

Royal Society K.C. Wong Fellowship, UK, 1995.

Session Chair, International Symposium on Tumor Targeted delivery Systems, NCI and CRS, Bethesda, MD. September 25 –27, 2000.

Finalist of 2006 Utah Innovation Awards.

Guest Editor on the Special Issue on Molecular Imaging, Molecular Pharmaceutics

Guest Editor on the Biomedical Imaging in Drug Discovery and Development, Pharmaceutical Research

Member of Editorial Board, Pharmaceutical Research

Member of Editorial Board, Molecular Pharmaceutics

Member of Editorial Board, ISRN Biomaterials.

Member of Editorial Board, American Journal of Nuclear Medicine and Molecular Imaging.

Member of Advisory Editorial Board, American Journal of Cancer Therapy and Pharmacology.

Moderator of the Symposium on Biomedical Imaging on Drug Discovery and Development at 2006 AAPS Annual Meeting

Co-Chair of the Workshop on Molecular Imaging and Drug Delivery at 2007 Annual Meeting of the Controlled Release Society

Organizing Committee, nanoUtah 2008

International Program Committee for the IASTED, 2012

Convenor, Symposium of Contrast Media Research, 2011-2013.

Moderator of the 2012 International Symposium of Controlled Release Society, 2012

Moderator of the NanoDDS’12, 2012

Moderator of the 2012 symposium of OCSMRM, 2012

PROFESSIONAL SOCIETIES

American Chemical Society

Controlled Release Society

International Society for Magnetic Resonance in Medicine

Society for Molecular Imaging

TEACHING ACTIVITIES

1. Pharmaceutics 5125, Dosage Forms and Drug Delivery Systems; professional Pharm.D. class, 50 students, three lecture hours, 2004 -2009, University of Utah

2. Pharmaceutics 7020 or 7040, Drug Stability-Kinetics and Mechanisms of Drug Degradation and Stabilization; core course for graduate students, course designer, since Fall, 2002 – 2009, University of Utah

3. Bioengineering 7120, BIOCOMPATIBILITY, two lecture hours, 2002 – 2009, University of Utah

4. Pharmaceutics 7110, Molecular Imaging; elective course for professional students and graduate students, course designer, 2005, University of Utah

5. Journal Club, Bioconjugate Chemistry; Fall 2000

6. Journal Club, Molecular Imaging; Spring 2004.

7. EBME426, Nanomedicine, Elective for Graduate Students, since 2010, Case Western Reserve University

8. EBME316/416, Drug Delivery, elective course for undergraduate students and graduate students, since 2010, Case Western Reserve University

9. Supervisor for the research of following undergraduate students

1. Nicole Polson (Access Research Program, Spring 2004)

2. Amanda Meldrum (Access Research Program, Spring 2005)

3. Thanh Nguyen (Access Research Program, Spring 2006)

4. Ronny Li (CWRU, 2009)

5. Hardy Han (CWRU, 2010)

6. Xiu-Feng Peng (CWRU, 2011)

7. Vivian Huynh (CWRU, 2011)

10. Supervisor for the research of following summer undergraduate students

1. Todd Kaneshiro (summer 2002, Pharmaceutics)

2. Todd Kaneshiro (summer 2003, HCI)

3. Melissa Smith (summer 2003, Pharmaceutics)

4. Nicole Polson (summer 2004, Pharmaceutics)

5. Matt Webber (summer 2004, Pharmaceutics)

6. Matt Webber (summer 2005, Pharmaceutics)

7. Bryce Hill (summer 2006, Pharmaceutics)

8. Thanh Nguyen (summer 2007, Pharmaceutics)

9. Thanh Nguyen (summer 2008, Pharmaceutics)

10. Melinda Fairman (summer 2008, Pharmaceutics)

11. Member of Advisory Committee for following graduate students

1. Scott Stayner (Bioengineering, graduated)

2. Yan Wang (Chemistry, graduated)

3. Travis Bridge (Chemistry)

4. Gang Zuo (Chemistry, graduated)

5. Hung Duong (Chemistry, graduated)

6. Zhuqing Liu (Chemistry, graduated)

7. Manfei Lee (Chemistry)

8. Vijay Sethuraman (Pharmaceutics, graduated)

9. Han Chang Kang (Pharmaceutics, graduated)

10. Weiwei Zhu (Pharmaceutics, graduated)

11. Jie Zhou (Chemistry)

12. Venkatareddy Nadithe (Pharmaceutics, graduated)

13. Vaikunth Cuchelkar (Bioengineering, graduated)

14. Xiaoyu Xu (Chemistry, graduated)

12. Supervisor for following rotating graduate students

1. Jeff C. Chang (Fall 2002)

2. Marisa Frost (Spring 2003)

3. Huifeng Gao (Spring 2004)

4. Rongzuo Xu (Spring 2005)

5. Clinton Jones (Fall 2006)

6. Zhen Ye (Fall 2007)

7. Imit Kauer (Fall 2008)

13. Supervisor for following graduate students

1. Aaron Mohs (Pharmaceutics, Ph.D., graduated in 2006, Post-Doctor in Emory University)

2. Anagha Vaidya (Pharmaceutics, Ph.D., graduated in 2008, Scientist in Abbott Laboratories)

3. Yi Feng (Material Science, Ph.D., graduated in 2007, Post-Doctor in Washington University, Nevada Cancer Center)

4. Furong Ye (Pharmaceutics, Ph.D., graduated in 2009)

5. Yuda Zong (Pharmaceutics, Ph.D., graduated in 2008, Scientist in Hercules Pharmaceutics)

6. Todd Kaneshiro (Pharmaceutics, Ph.D., graduated in 2008, Volunteer for USA Government in Central Asia)

7. Rongzuo Xu (Pharmaceutics, Ph.D., graduated in 2009, Post-Doctor in J&J)

8. Brandon Buckway (Pharmaceutics, Ph.D., transferred)

9. Zhen Ye (Pharmaceutics, Ph.D., expected to graduate in 2011)

10. Anthony Malamas (Biomedical Engineering, Ph.D. Case)

11. Anthony Puntel (Biomedical Engineering, Ph.D. Case)

12. Zheng Han (BME, Ph.D. Case)

13. Maneesh Gujrati (BME, Ph.D. Case)

14. Supervisor for following postdoctoral fellows or visiting scientists

1. Xinghe Wang (August 2002 – July 2004, Principal Scientist in a company in San Diego, CA)

2. Tianyi Ke (January 2004 – June 2006, Senior Scientist in a company  at LA, CA)

3. Xuli Wang (March 2004-June 2008, Research Assistant Professor, University of Utah)

4. Yanli Wang (January 2005 – June 2006, Manager in a company in Salt Lake City, Utah)

5. Xueming Wu (since May 2007-)

6.  Mingqian Tan (October 2007 – November 2010, Associate Professor in Dalian Institute of Chemical Physics, Chinese Academy of Science)

7.  Wanjian Jia (since January – May, 2009, post-doctor at University of Utah)

8. Shuoyu Yin (November, 09 – May, 2010, Professor in Yanji University, China)

9. China Kimmitha (March, 2010 -2011)

10. Emhonta Johnson (August, 2010 – July, 2011)

11. Chengcai Luo (August, 2010 - August, 2011, Assistant Professor in Zhejiang University )

12. Bharath Guru (March 2011 -2012)

13. Zhuxian Zhou (May, 2011  -

14. Erlei Jin (June, 2011 -)

Awards received by students under my supervision

A.M. Mohs: Fox Award, Wolf Award, PhRMA Fellowship

A. Vaidya: Fox Award, 2nd place award of the best poster in the 2006 Annual Meeting of International Society of Magnetic Resonance in Medicine (ISMRM).

T. Kaneshiro: American Heart Association Graduate Student Fellowship, Top Prize of Best Students’ Poster Award of 2007 Annual meeting of the Controlled Release Society.

SERVICE ACTIVITIES

Grant reviewer for following agencies

1. The Petroleum Research Fund, 2002.

2. The Italian National Research Council, 2003.

3. The U.S. Civilian Research & development Foundation, 2004.

4. Hong Kong Research Grants Council, 2004, 2005, 2007, 2008.

5. University of Utah Seed Grant, since 2004.

6. The American Heart Association Bioengineering and Biotechnology 1. Peer Review Group, Member, 2005 -.

7. Israel Science Foundation, 2006, 2007.

8. NIBIB/NIH Innovation In Molecular Imaging Probes Roadmap Grant Review Special Emphasis Panel ZEB1 OSR-C M1, Member, March 2005.

9. NIBIB/NIH review panel for the NIBIB Quantum Program, 2006.

10. Ohio Cancer Research Associates, 2007, 2008.

11. National Science Foundation, 2006, 2007.

12. Singapore Biomedical Research Council, 2006, 2007

13. Alberta Cancer Board, 2007

14. NIH ZRG1 F14 Special Emphasis Panel, 2008

15. NIH Medical Imaging Study Section, 2008

16. NIH Medical Imaging Study Section A, 2008

17. NIH Special Emphasis Panel ZRG1 F14-G, 2008

18. NIH Special Emphasis Panel ZRG1 F14-G, 2009

19. NIH Medical Imaging Study Section A, 2009

20. NIH Clinical Molecular Imaging and Probe Development Study Section A, since 2009

Manuscript reviewer for following journals

Advanced Drug Delivery Reviews

Angewante Chem.

European Journal of Pharmaceutics and Biopharmaceutics

International Journal of Pharmaceutics

Journal of Pharmacy and Pharmacology

Journal of the American Chemical Society

Biomacromolecules

Langmuir

Journal of Controlled Release

PDA Journal of Pharmaceutical Science and Technology

Pharmaceutical Research

Journal of Polymer Science

Australia Journal of Chemistry

Journal of Drug Targeting

Polymer International

Journal of Biomedical Materials Research, Part A

Journal of Biomedical Materials Research, Part B

Journal of Biological Chemistry

Bioconjugate Chemistry

Biomaterials

Macromolecules

Magnetic Resonance in Medicine

Macromolecular Bioscience

Nanomedicine

Journal of Applied Polymer Science

Advanced Functional Materials

Journal of Medicinal Chemistry

Molecular Pharmaceutics

Technology in cancer research and treatment

Journal of Gene Medicine

Current Opinion in Molecular Therapeutics

Journal of Cellular and Molecular Medicine

Tetrahedron Letters

Chemical Communications

Colloids and Surfaces B: Biointerfaces

Molecular Imaging

Cancer Research

Nature Communication

Contrast Media and Molecular Imaging

Abstract reviewer for following scientific conferences

The 30th Annual Meeting of the Controlled Release Society, 2003

The 31st Annual Meeting of the Controlled Release Society, 2004

The 2004 Annual Meeting of American Association of Pharmaceutical Scientists

The 2005 Annual Meeting of American Association of Pharmaceutical Scientists

The 2005 Annual Meeting of the International Society of Magnetic Resonance in Medicine

The 2008 Annual Meeting of the International Society of Magnetic Resonance in Medicine

The 2009 Annual Meeting of the International Society of Magnetic Resonance in Medicine

The 38th Annual Meeting of the Controlled Release Society, 2011

The 39th Annual Meeting of the Controlled Release Society, 2012

Services in the Committees:

The Chair Search Committee of the Department of Pharmaceutics (Member, 2004)

The Chair of Seminar Series of the Department of Pharmaceutics (spring, 2004)

The College Learning and Teaching Committee (Member, 2001-2003, 2004 -)

The College Research and Graduate Program Committee (Member, 2003-2004)

The University Seed Grant Committee (Member, 2004 - 2007)

The Department Graduate Student Admission Committee (Chair, 2004 - 2008)

The program committee of the Biotechnology Section of the American Association of Pharmaceutical Scientists (Member, 2005)

The Academic Senate of University of Utah (2006 - 2009)

The Personnel and Selection Committee, University of Utah (2006 -2008)

New Faculty Search Committees (Chair for one of the committees, CWRU, 2009)

Graduate Education Committee (BME, CWRU, 2009 -)

Faculty Senate of Case Western Reserve University (2011 -)

Community Service

Volunteer for Salt Lake City Figure Skating Club (2004 - 2007)

RESEARCH AND SCHOLARLY ACTIVITIES

Current Research Grant Awards

R01 EB000498-01 (NIH/NIBIB) Lu (PI) 07/01/03 – 03/31/15

Biodegradable macromolecular blood pool contrast agents. The major goal is to design and develop safe, effective MRI blood pool contrast agents based on biodegradable macromolecular gadolinium (III) complexes. The research project is focused on contrast enhanced MR cardiovascular imaging.

R01 CA097465 (NIH/NCI) Lu (PI) 03/01/04 – 04/30/12

Polymer chelate conjugates for diagnostic cancer imaging. The major goal is to develop effective, safe targeted polymer-gadolinium chelate conjugates for specific MR diagnostic cancer imaging.

R24EY021126 (NIH/NEI) Lu (Co-I)

10/01/10-09/30/15

Pharmacological Treatment of Retinal Diseases. The major goal is to develop new drug delivery systems for sustained release of retinal therapeutics.

Completed Research Grants and Contracts

R41CA135785 (NIH/NCI) Lu (PI)

07/01/09-06/30/10

Multifunctional Carriers for siRNA Delivery. The major goal is to develop novel safe and effective multifunctional delivery systems for therapeutic siRNA.

R31 CA095873-01 (NIH/NCI) Lu (PI) 06/01/03 – 05/31/04

Biodegradable macromolecular MRI contrast agents. The major goal is to design and develop biodegradable macromolecular gadolinium (III) complexes for cancer imaging. The research project is focused on the detection and staging of cancer in animal models.

Nitto Denko Technical Corp. Lu (PI) 07/01/02 – 06/30/04

Characterization of polymeric gene carriers

University of Utah Technology Commercialization Projects, Lu (PI) 07/01/05 – 06/30/07

Preclinical development of biodegradable macromolecular MRI contrast agents. The major goal is to evaluate the toxicity and pharmacokinetics of the two new biodegradable macromolecular MRI contrast agents.

University of Utah Technology Commercialization Projects, Lu (PI)

07/01/08 – 06/30/09

Multifunctional Carriers for siRNA delivery. The major goal is to develop efficient multifunctional delivery systems for siRNA.

Utah Center of Excellent Program Award, Lu (PI)

07/01/08 – 06/30/09

Center of Nanomedicine Applications in Cancer. The goal of the center to develop and commercialize imaging agents using drug delivery technology.

The CAO Group, Inc. 07/01/06-06/30/07

Laser ablation in animal tumor model.

R33 CA095873-01 (NIH/NCI) Lu (PI) 06/01/04 – 05/31/08

Biodegradable macromolecular MRI contrast agents. The major goal is to design and develop biodegradable macromolecular gadolinium (III) complexes for cancer imaging. The research project is focused on the detection and staging of cancer in animal models.

R41CA128130 (NIH/NCI) Lu (PI)

07/01/08-06/30/09

Minimally-invasive image-guided therapy for cancer treatment. The major goal is to develop minimally invasive cancer therapy to treat pancreatic cancer.

Case Cancer Center CCIR Seed Grant

10/01/09-09/30/10

Molecular Imaging of the Prostate Tumor Microenvironment. The major goal is to develop novel imaging probes for molecular imaging of the microenvironment of prostate cancer.

PEER Reviewed Publications

1. Y. Zhou, S. Wu, Z.-R. Lu

Synthesis of the derivatives of biscyclopentadienylzirconium (IV) with N,N-

dialkyldithiocarbamates

J. Lanzhou University (Sci. Ed.), 1987, 23(4), 152-53

2. Z.-R. Lu, Y.-Q. Yin, D.-S. Jin

Novel catalysts for the epoxidation of cyclohexene with t-butyl hydroperoxide

J. Mol. Catal. (China), 1989, 4, 276-283. CA 113, 39824

3. Z.-R. Lu, Y.-Q. Yin, D.-S. Jin

Catalytic Epoxidation of Olefin

Huaxue Jinzhan (Progress in Chem.) 1990,1,17-28

4. Z.-R. Lu, Q. Guo, Y.-Q. Yin, D.-S. Jin

Epoxidation of alkene catalyzed by vanadatranes

J. Mol. Catal. (China), 1991, 2, 139. CA 115, 231488

5. Z.-R. Lu, Y.-Q. Yin, D.-S. Jin

Molybdenum catalysts for propylene epoxidation

Chinese J. of Appl. Chem., 1991, 8(5), 49-51. CA 116, 40848

6. Z.-R. Lu, Y.-Q. Yin, D.-S. Jin

Oxidation of alkene with t-butyl hydroperoxide catalyzed by copper complexes of

tris(2-benzimidazolylmethyl)amine: model complexes of blue copper proteins

J. Mol. Catal., 1991,70, 391-397

7. Z.-R. Lu, Q. Guo, Y.-Q. Yin, D.-S. Jin

Epoxidation of cyclohexene with aqueous hydrogen peroxide catalyzed by 1,1-

dioxomolybdatranic acids

J. of Catal. (Cuihua Xuebao), 1992,13(3), 198-202. CA 117, 111395

8. Z.-R. Lu, Y.- Q. Yin, D.-S. Jin

Synthesis and reactivity of oxoperoxomolybdenum (VI) complexes: the active species in the Halcon epoxidation process

Chinese Chem. Lett., 1992, 3, 1003-6

9. Z.-R. Lu, S.-Q. Gao, Y. Zhou, S. Wu

Synthesis and characterization of cyclopentadienyl(or methylcyclopentadienyl)-

titanium(IV), zirconium (IV) triscarbamates

Chinese J. of Appl. Chem., 1992, 9(3), 110-113. CA 117, 151099

10. Z. Wang, S. Lu, H, Guo, Z.-R. Lu, Y.-K. Zhou

Aqueous phase synthesis of dicarboxylic derivatives of the titanocene

Synth. React. Inorg. Met. Org. Chem. 1992, 22, 883-892

11. Z.-R. Lu, J. Liao, R.-X. Zhuo

2-Hydroxyethylation of L-amino acids with chlorohydrin : synthesis of L-N-2-

hydroxyethyl amino acids and L-N,N-bis(2-hydroxyethyl)amino acids

Chinese Chem. Lett., 1993,4, 689-692

12. R.-X. Zhuo, Z.-R. Lu, J. Liao, L.-F. Shen

Synthesis and characterization of (4S)-silatrane-4 -carboxylic acids; molecular

structure of (3R,4S)-1-vinyl-3-methylsilatrane-4-carboxylic acid

J. Organomet. Chem., 1993, 446, 107-112

13. Z.-R. Lu, C.-Y. Tao, R.-X. Zhuo

Synthesis of (4S)-ethoxysilatrane-4-carboxylic acids

Chinese Chem. Lett., 1994, 5, 549-50

14. Z.-R. Lu, R.-X. Zhuo, L.-R. Shen, B.-S. Luo

The synthesis and crystal structure of (4S)-(3-chloropropyl)silatrane-4-carboxylic

acid monohydrate: a stable intermediate in the hydrolysis of silatrane

Main Group Metal Chem., 1994, 17, 377-85

15. Z.-R. Lu, S.-Q. Gao, Y. Zhou, S. Wu

Aquachemistry of titanocene dichloride and crystal structure of titanocene

bissalicylate

Chinese J. of Appl. Chem., 1994, 11, 28-32

16. Z.-R. Lu, Y.-Q. Yin, D.-S. Jin

Oxidation of cyclohexene with sodium hypochloride or t-butyl hydroperoxide

catalyzed by Fe(III),Co(II), and Ni(II) complexes of tris(2-benzimidazolylmethyl)-amine

J. Mol. Catal. (China), 1994, 8, 143-46

17. Z.-R. Lu, R.-X. Zhuo, L. Shen, X. Zhang, L.-F. Shen

Synthesis and characterization of (4S)-1-chloroalkylsilatrane-4-carboxylic acids,

crystal structures of (3R,4S)-1-chloromethyl-3-methylsilatrane-4-carboxylic acid and (3R,4S)-1-(3-chloropropyl)-3-methylsilatrane-4-carboxylic acid

J. Organomet. Chem., 1995, 489, C38-C43

18. Z.-X. Zhuo, Z.-R. Lu, J. Wen

Synthesis and characterization of metal complexes of L-lysine-N,N,N',N'-tetraacetic acid and L-lysine-N,N,N',N'-tetramethylenephosphonic acid

Chemical Research in Chinese Universities, 1995, 11, 276-78

19. X. Zhang, S. Mao, L. Shen, C. Ye, R.-X. Zhuo, Z.-R. Lu, G. A. Webb

Conformational analysis of some substituted silatranyl carboxylic acids produced by computational study and NMR spectroscopy

J. Mol. Struct. 1995, 372, 249-56

20. Z.-R. Lu, R.-X. Zhuo, C. Yin

Synthesis and relaxivity of Gd(III) complexes with EDDS and THEC

Gaodeng Xuexiao Huaxue Xuebao, 1996, 1, 24-26

21. R.-X. Zhuo, G. Fu, M. Ouyang, X. Zhao, Z.-R. Lu

Modified DTPA, EDTA ligands and their paramagnetic metal complexes as contrast agents for MRI

Wuhan Univ. J. Nat. Sci. 1996, 1(2), 225-29

22. C. Eaborn, Z.-R. Lu, P.B. Hitchcock, J.D. Smith

_________________________________

[CH2-SiMe2(SiMe3)2C-Li-C(SiMe3)SiMe2CH2] and

__________________________________

[CH2-SiMe2(SiMe3)2C-Hg-C(SiMe3)SiMe2CH2] the highly crowded chelated

organomercury compounds

Organometallics, 1996, 15(6), 1651-55

23. C. Eaborn, P. Hitchcock , K. Izod, Z.-R. Lu, J.D. Smith

Alkyl derivatives of Europium(+2), Ytterbium(+2), Crystal structures of

Eu[C(SiMe3)3]2, and Yb[(CSiMe3)2(SiMe2CH=CH2)]I.OEt2 and

Yb[C(SiMe3)2(SiMe2OMe)]I.OEt2

Organometallics, 1996, 15(22), 4783-90

24. C. Eaborn, P. Hitchcock, A. Kowalewska, Z-R. Lu, J.D. Smith, W. Stanczy

Iodo(methoxydimethylsilyl)bis(trimethylsilyl)methane, A reagent for the preparation of novel organometallic compounds, crystal structures of

_________________

Mg{C(SiMe3)2(SiMe2OMe)}2 and Mg(OEt2)2I2

J. Organometallic Chem. 1996, 521(1-2), 113-120

25. T.-Y. Ke, R.-X. Zhuo, Z.-R. Lu, H.-Q. Feng

Phosphorylating polycondensation using phosgene as a chain extender

European J. Polymer, 1997, 33, 1583-86

26. Z.-R. Lu, J.-H. Yu, R.-X. Zhuo

Synthesis of new ointment-like poly(ortho esters)

Chinese Chem. Lett. 1997, 8(2), 114-6

27. X.-D. Zhang, S.-Z. Mao, L.-F. Shen, Z.-R. Lu, R.-X. Zhuo

NMR and Molecular dynamics study on some substituted silatranes

Acta Chimica Sinica, 1997, 55(3), 290-95

28. X. Zhao, R.-X. Zhuo, Z.-R. Lu, W. Liu

Synthesis, characterization and relaxivity of amphiphilic chelates of DTPA

Derivatives with GdIII, YbII and MnII

Polyhedron, 1997, 16(16), 2755-59

29. Z. Liu, Y. Qi, X. Zhou, Z.-R. Lu, G. Xiao

A novel approach for gene transfer using porphyrin-dendritic macromolecular

conjugates

Biotechnology Techniques, 1997, 11(8), 601-4

30. Z.-R. Lu, J.-H. Yu, R.-X. Zhuo, X.-L. Wang, F.-H. Yang

Studies on the preparation and cytotoxicity of poly(L-aspartic acid) derivative-

cisplatin(II) conjugates

Gaodeng Xuexiao Huaxue Xuebao, 1998, 19(5), 817-820

31. X.-D. Zhang, G. Zheng, L.-F. Shen, C.-H. Ye, Z.-R. Lu, R.-X. Zhuo

Solid sate NMR study of some substituted silatrane compounds

Acta Chimica Sinica, 1998, 56, 986-989

32. J.-L. Liu, S.-H. Shi, R.-X. Zhuo, Z.-R. Lu

Preparation of dendrimers from macromolecular cores and papain immobilization

Chinese Chem. Lett. 1998, 9, 263-264

33. R.-X. Zhuo, B. Du, Z.-R. Lu

In vitro release of 5-fluorouracil with cyclic core dendritic polymers

J. Control. Release, 1999, 57, 249-257

34. Z.-R. Lu, P. Kopeckova, Z. Wu, J. Kopecek

Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification

Bioconjugate Chem., 1998, 9(6), 793-804

35. Z.-R. Lu, P. Kopeckova, Z. Wu, J. Kopecek

Synthesis of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] by radical

polymerization in the presence of alkyl mercaptans

Macromol. Chem. Phys., 1999, 200, 2022-2230

36. Z.-R. Lu, P. Kopeckova, J. Kopecek

Polymerizable Fab' fragment for targeting of anticancer drugs

Nature Biotechnology, 1999, 17(11), 1101-1104

37. Z.-R. Lu, S.-Q. Gao, P. Kopeckova, J. Kopecek

Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates for

treatment of colon diseases

Bioconjugate Chem., 2000, 11(1), 3-7

38. J. Kopecek, P. Kopeckova, T, Minko, Z.-R. Lu

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

Eur. J. Pharmaceutics Biopharm., 2000, 50, 61-81

39. Jiahui Yu, Zheng-Rong Lu, Hua Zheng and Renxi Zhuo, Synthesis and characterization of new ointment–like poly(ortho esters)

Eur. Polymer Journal, 2001, 38 971-975.

40. Z.-R. Lu, S.-Q. Gao, P. Kopeckova and J. Kopecek

Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers

Bioconjugate Chem., 2001, 12, 129-133

41. Y. Kasuya, Z.-R. Lu, P. Kopeckova, T. Minko, E. Tabibi and J. Kopecek

Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates

J. Control. Release, 2001, 74, 203-11.

42. Y. Kasuya, Z.-R. Lu, P. Kopeckova, and J. Kopecek

Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems

Bioorganic & Medicinal Chemistry Letters. 2001, 11, 2089-2091

43. J. Kopecek, P. Kopeckova, T. Minko, Z.-R. Lu, C.M. Peterson

Water soluble polymers in tumor targeted delivery

J. Control. Release, 2001, 74, 147-58.

44. L. Varticovski, Z.-R. Lu, I. de Aos, T. Kagawa, K. Mitchell, R. Christensen, and J. Kopecek

A water-soluble HPMA copolymer–wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo

J. Control. Release, 2001, 74, 275-81.

45. Z.-R. Lu, J.-G. Shiah, P. Kopeckova and J. Kopecek

Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system

J. Control. Release, 2001, 74, 263-8.

46. S. Sakuma, Z.-R. Lu, P. Kopeckova and J. Kopecek.

Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin

J. Control. Release, 2001, 75, 365-79.

47. Z.-R. Lu, J.-G. Shiah, S. Sakuma, P. Kopeckova and J. Kopecek,

Design of novel bioconjugates for targeted drug delivery

J. Control. Release, 2002, 78, 165-73.

48. Y. Luo, N. Bernshaw, Z.-R. Lu, J. Kopecek and G.D. Prestwich,

Hyaluronic acid containing bioconjugates: targeted delivery of anticancer drug doxorubicin to cancer cells

Pharm. Res., 2002, 19, 396-402.

49. Y. Kasuya, Z.-R. Lu, P. Kopeckova and J. Kopecek,

Improved Synthesis and Evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems

Bioorg. Med. Chem. Letters. 2001, 11, 2089-91.

50. Y. Kasuya, Z.-R. Lu, P. Kopeckova, S. E. Tabibi and J. Kopecek,

Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates

Pharm. Res. 2002, 19, 115-123.

51. S. Sakuma, Z.-R. Lu, B. Pecharova, P. Kopeckova and J. Kopecek.

N-(2-Hydroxypropyl)methacrylamide copolymer-9-aminocamptothecin conjugate: colon-specific drug delivery in rats

J. Bioact. Comp. Polym. 2002, 17, 305-319.

52. Z.-R. Lu, J.-G. Shiah, P. Kopeckova and J. Kopecek

Polymerizable Fab' antibody fragments targeted photodynamic cancer therapy in nude mice

STP Pharm. Sci. 2003, 13, 69-75.

53. Z.-R. Lu, P. Kopeckova and J. Kopecek

Antigen responsive hydrogels based on polymerizable antibody Fab' fragment Macrom. Biosci. 2003, 3, 296-300.

54. Z.-R. Lu, X. Wang, D.L. Parker, K.G. Goodrich, H.R. Buswell.

Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging

Bioconjugate Chem. 2003, 14, 715-719.

55. Z.-R. Lu, D. L. Parker, K. C. Goodrich, J. Dalle, H. R. Buswell.

Extracellular biodegradable macromolecular gadolinium(III) complexes for magnetic resonance imaging

Magn. Reson. Med. 2004, 51, 27-34.

56. A. M. Mohs, X. Wang, K. C. Goodrich, Y. Zong, D. L. Parker, Z.-R. Lu

Poly(GdDTPA-L-cystine)-g-PEG: a biodegradable macromolecular blood pool contrast agent for MR imaging

Bioconjugate Chem. 2004, 15, 1424-1430.

57. Y. Zong, X. Wang, K. C. Goodrich, A. M. Mohs, D. L. Parker, Z.-R. Lu

Contrast enhanced tumor MRI with new biodegradable macromolecular Gd(III) complexes in mice

Magn. Reson. Med. 2005, 53, 835-42.

58. X.Wang, H. Y. Feng, T. Ke, M. Schable, Z.-R. Lu

Pharmacokinetics and long-term Gd tissue accumulation of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular MRI contrast agent

Pharm. Res. 2005, 22, 596-601.

59. A. M. Mohs, Y. Zong, J. Guo, D. L. Parker, and Z.-R. Lu

PEG-g-Poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI

Biomacromolecules. 2005, 6, 2305-11.

60. Z.-R. Lu, A.M. Mohs, Y. Zong and Y. Feng

Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents

Intl. J. Nanomed. 2006,1, 31-40.

61. S.Q. Gao, Z.R. Lu, B. Petri, P. Kopeckova, J. Kopecek.

Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer

J. Control. Release. 2006, 110, 323-31.

62. T. Kaneshiro, T. Ke, EK Jeong, D.L. Parker and Z.-R. Lu

(Gd-DTPA)-(L-cystine bisalkylamide) copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging

Pharm. Res. 2006, 23, 1285-94.

63. Y. Zong, T. Ke, A.M. Mohs, J. Guo, D.L. Parker, Z.-R. Lu

Effect of size and charge on in vivo MRI contrast enhancement of polydisulfide Gd(III) complexes

J. Controlled Rel. 2006, 112, 350-6.

64. Y. Feng, Y. Zong, T. Ke and Z.-R. Lu

Pharmacokinetics and blood pool contrast enhancement of Gd-DTPA Cystine Copolymers and Gd-DTPA Cystine Diethyl Ester Copolymers

Pharm. Res. 2006, 23, 1736-1742.

65. T. Ke, Y. Feng, J. Guo, D. L. Parker, Z.-R. Lu

Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DOTA conjugates for contrast enhanced MR imaging

MRI. 2006, 24, 931-40.

66. A. Vaidya, Y. Sun, T. Ke, E.K. Jeong, Z.-R. Lu

MRI guided photodynamic therapy for specific cancer treatment

MRM, 2006, 56, 761-7.

67. Z.-R. Lu.

What can you see with imaging in pharmaceutical research?

Mol. Pharm. 2006, 3, 471.

68. T. D. Nguyen, P. Spincemaille, A. Vaidya, M. R. Prince, Z.-R. Lu, Y. Wang.

Biodegradable intravascular (Gd-DTPA)-cystamine copolymer for contrast-enhanced steady-state free precession magnetic resonance angiography: comparison with MS-325 in a swine model

Mol. Pharm. 2006, 3, 558-565.

69. F. Ye, T. Ke, E.-K. Jeong, M. Johnson, Z.-R. Lu

Visualization of size effect of poly(L-glutamic acid) in drug delivery with contrast enhanced MR imaging

Mol. Pharm. 2006, 3, 507-515.

70. T. Ke, E.K. Jeong, X. Wang, Y. Feng, D.L. Parker, Z.-R. Lu

RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DOTA) for MR imaging of angiogenesis

Intl. J. Nanomed. 2007, 2, 191-9.

71. S.Q. Gao, Z.R. Lu, P. Kopeckova, J. Kopecek

Biodistribution and pharmacokinetics of colon-specific HPMA copolymer-9-aminocamptothecin conjugate in mice

J. Controlled Rel. 2007, 117, 179-185.

72. Y. Wang, F. Ye, E.-K. Jeong, Y. Sun, D. L. Parker, Z.-R. Lu.

Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[N-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced MRI Pharm. Res. 2007, 6, 1208-16.

73. A Mohs, Z.-R. Lu

Gadolinium(III)-Based Blood Pool Contrast Agents for Magnetic Resonance Imaging: Current Status and Clinical Potential

Expert Opinion on Drug Delivery. 2007, 4, 149-164.

74. A. Mohs, T. Nguyen, E.-K. Jeong, Y. Feng, L. Emerson, Y. Zong, D.L. Parker, Z.-R. Lu

Pegylation of Gd-DTPA Cystine Copolymers Improves Pharmacokinetics and Tissue Retention for Magnetic Resonance Angiography

MRM. 2007, 58, 110-8.

75. T.L. Kaneshiro, XL Wang, Z.-R. Lu

Synthesis and Characterization of Globular L-Lysine Dendrimers with a Cubic Octa(3-aminopropyl)silsesquioxane Core

Mol. Pharm. 2007, 4, 759-68.

76. R. Xu, Y. Wang, X. Wang, E.-K. Jeong, D.L. Parker and Z.-R. Lu

In Vivo Evaluation of a PAMAM-Cystamine-(Gd-DO3A) Conjugate as a Biodegradable Macromolecular MRI Contrast Agent

Exp. Biol. Med. 2007, 232, 1081-9.

77. Z.-R. Lu

Application of biomedical imaging in drug discovery and development

Pharm. Res. 2007, 6, 1170-1.

78. X.L. Wang, R. Jensen, and Z.-R. Lu

A novel environment-sensitive biodegradable cationic polydisulfide with protonatable pendents for nucleic acid delivery

J. Control. Rel. 2007, 120, 250-8.

79. S. Sakuma, T. Matsumoto, S. Yamashita, Y. Wang, Z.-R. Lu

Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs

J. Control. Rel. 2007, 123, 195-202.

80. Z.-R. Lu, F. Ye and A. Vaidya.

Polymer Platform for Drug Delivery and Biomedical Imaging

J. Control. Release. 2007. 122, 269-77.

81. X.-L. Wang, S. Ramusovic, T. Nguyen, Z.-R. Lu.

Novel polymerizable surfactants with pH sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery

Bioconjugate Chem. 2007, 18, 2169-77.

82. F. Ye and Z.-R. Lu

Biomedical polymers for drug delivery and biomedical imaging

Pharma Focus Asia, invited paper, 2007, 5, 43-45.

83. X.-L. Wang, T. Nguyen, D. Gillespie, R. Jensen, Z.-R. Lu

A multifuncational and reversibly polymerizable carrier for efficient siRNA delivery Biomaterials, 2008, 29, 15-22.

84. A. Vaidya, Y. Sun, Y. Feng, L. Emerson, E.-K. Jeong, Z.-R. Lu

Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer-drug conjugate

Pharm. Res. 2008, 25, 2002-11.

85. T. Paunesku, T. Ke, R. Dharmakumar, N. Mascheri, A. Wu, B. Lai, S. Vogt, J. Maser, K. Thurn, B. Szolc-Kowalska, A. Larson, R. C. Bergan, R. Omary, D. Li, Z.-R. Lu, G. E. Woloschak.

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

Nanomedicine. 2008, 4, 301-7.

86. Y. Feng, E.-K. Jeong, A. Mohs, L. Emerson, Z.-R. Lu

Characterization of tumor angiogenesis with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice

MRM. 2008, 60, 1347-52.

87. T. Kaneshiro, EK Jeong, D.L. Parker and Z.-R. Lu

Synthesis and Evaluation of Globular Gd-DO3A Conjugates with Precisely Controlled Nanosizes for Magnetic Resonance Angiography

Biomacromolcules, 2008, 9, 2742-8.

88. F. Ye, X. Wu, EK Jeong, D.L. Parker and Z.-R. Lu

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI

Bioconjugate Chemistry, 2008, 19, 2300-3.

89. X.-L. Wang, R. Xu, Z.-R. Lu.

Functionalization of a polymerizable pH-sensitive amphiphilic surfactant for efficient ligand-directed siRNA delivery.

J. Controlled Release, 2009, 134, 207-13.

90. Y. Zong, X. Wang, EK Jeong, D.L. Parker and Z.-R. Lu

Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents

MRI, 2009, 27, 503-11.

91. X.-L. Wang, R. Xu, X. Wu, D. Gillespie, R. Jensen, Z.-R. Lu.

Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice

Molecular Pharmaceutics, 2009, 6, 738-46.

92. Y. Feng, X. Wu, L. Emerson, E.-K. Jeong, DL Parker, Z.-R. Lu

Tumor differentiation based on angiogenesis with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice

Pharm. Res. 2009, 26, 2202-8.

93. Y. Feng, L. Emerson, E.-K. Jeong, DL Parker, Z.-R. Lu

Non-invasive assessment of the efficacy of indocyanine green enhanced photothermal cancer therapy with dynamic contrast enhanced MRI using a biodegradable macromolecular contrast agent

JMRI. 2009, 30, 401-6.

94. T. Kaneshiro and Z.-R. Lu,

Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier

Biomaterials, 2009, 30, 5660-6.

95. X, Liu, Y. Feng, Z.-R. Lu, G. Morrell, E.K. Jeong

Rapid simultaneous acquisition of T(1) and T(2) mapping images using multishot double spin-echo EPI and automated variations of TR and TE (ms-DSEPI-T12).

NMR Biomed. 2010, 23, 97-104.

96. X. Wu, L. Emerson, E.-K. Jeong, DL Parker, JM Hoffman, Z.-R. Lu

Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.

Mol. Pharm. 2010, 7, 41-8.

97. Z.-R. Lu

Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.

Adv Drug Deliv Rev. 2010, 62, 246-57. .

98. Tan M, Wu X, Jeong EK, Chen Q, Lu ZR.

Peptide-Targeted Nanoglobular Gd-DOTA Monoamide Conjugates for Magnetic Resonance Cancer Molecular Imaging.

Biomacromolecules. 2010, 11, 754-61.

99. Xueming Wu, Yuda Zong, Zhen Ye, and Zheng-Rong Lu

Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats

Pharm. Res. 2010, 27, 1390-7.

100. Mingqian Tan, Xueming Wu, Eun-Kee Jeong, Dennis L. Parker, Qianjin Chen, Zheng-Rong Lu

A Targeted Nanoglobular Manganese(II) Chelate Conjugate for Magnetic Resonance Molecular Imaging of Tumor Stroma

Mol. Pharm. 2010, 7, 936.

101. R. Xu, E.-K. Jeong, D.L. Parker and Z.-R. Lu

Synthesis and evaluation of novel biodegradable nano-sized MR contrast agent for DCE-MR urography: nanoglobule-G4-cystamine-(Gd-DO3A).

Intl. J. Nanomedicine. 2010, 5, 707.

102. Zheng-Rong Lu, Xueming Wu.

Polydisulfide-based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agent

Isr. J. Chem. 2010, 50, 1-12.

103. R. Xu, Xuli Wang and Z.-R. Lu

New surfactants forming pH-sensitive nanoparticles for nucleic acid delivery

Langmuir, 2010, 26, 13874.

104. R. Xu and Z.-R. Lu

Design, synthesis and evaluation of spermine-based pH-sensitive amphiphilic gene delivery systems

Science China Chemistry, 2011, 54, 359-368. (invited)

105. M. Tan and Z.-R. Lu

Integrin targeted MRI imaging

Theranostics, 2011, 1 83-101.

106. Mingqian Tan, Zhen Ye, Eun-Kee Jeong, Xueming Wu, Dennis L. Parker, Zheng-Rong Lu

Synthesis and Evaluation of Nanoglobular Macrocyclic Mn(II) Chelate Conjugates As Non-Gadolinium(III) MRI Contrast Agents

Bioconjugate Chem. 2011, 22, 913-7.

107. Shi X, Liu X, Wu X, Lu ZR, Li SK, Jeong EK.

Ocular Pharmacokinetic Study Using T(1) Mapping and Gd-Chelate- Labeled Polymers.

Pharm Res. 2011, 28, 3180-8.

108. Furong Ye, Eun-Kee Jeong, Denis Parker and Zheng-Rong Lu

Evaluation of CLT1-(Gd-DTPA) for Cancer MR Molecular Imaging in a Mouse Breast Cancer Model

Chinese J. Magn. Reson. 2011, 2, 325-330, (invited paper).

109. Zhen Ye,1 Eun-Kee Jeong,2 Xueming Wu,3 Mingqian Tan,3 Shouyu Yin,3 and Zheng-Rong Lu3*

New Polydisulfide Manganese(II) Complexes as Biodegradable Macromolecular MRI Contrast Agents

JMRI, 2012, 35, 737-44.

110. Mingqian Tan, Susan M. Burden-Gulley, Wen Li, Xueming Wu, Daniel Lindner, Susann M. Brady-Kalnay, Vikas Gulani, and Zheng-Rong Lu

MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model. Pharm. Res. 2012, 29, 953-60. Reviewed by the Faculty of 1000 as top 2% research paper in biology and medicine.

111. Zheng-Rong Lu

pH-Sensitive siRNA Delivery Systems,

J Drug Del Sci Tech. 2012, 1, 55-63. (invited paper)

112. Rongzuo Xu, Xuli Wang, Zheng-Rong Lu

Evaluation of Novel Spermine Based Surfactant Carriers On siRNA Delivery.

Chinese Science Bulletin, 2012, 57, 3979-3984 (invited paper)

113. China Malakondaiah Kummitha, Anthony S. Malamas, Zheng-Rong Lu*

Albumin enhances intracellular uptake of multifunctional amphiphile/siRNA nanoparticles for siRNA delivery.

Intl. J. Nanomedicine, 2012, 7, 5205-14.

114. Xueming Wu1, Mingqian Tan 1, Susan M. Burden-Gulley 2, Susann M. Brady-Kalnay, and Zheng-Rong Lu1

Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR cancer molecular imaging.

Bioconjugate Chem. 2012, 23, 1548-56.

115. Susan M. Burden-Gulley, Mohammed Q. Qutaish, Kristin E. Sullivant, Mingqian Tan, Sonya E.L. Craig, James P. Basilion, Zheng-Rong Lu, David L. Wilson and Susann M. Brady-Kalnay,

Molecular recognition of the dispersed cell population of glioma tumors at the single cell level using a targeted fluorescent PTPmu probe

International J. of Cancer, 2013 Apr 1;132(7):1624-32..

116. Zhuxian Zhou, Zheng-Rong Lu

Gadolinium-Based Contrast Agents for MR Cancer Imaging

WIREs Nanomedicine & Nanobiotechnology, 2013, 5, 1-18.

117. April M. Chow, Mingqian Tan, Darwin S. Gao, Shu Juan Fan, Jerry S. Cheung, Zhongwei Qiao, Kwan Man, Zheng-Rong Lu, Ed X. Wu

Molecular MRI of Liver Fibrosis by a Peptide Targeted Contrast Agent in an Experimental Mouse Model

Investigative Radiology, 2013, 48, 46-54.

118. Zhen Ye, Xueming Wu, Mingqian Tan, Jack Jesberger, Mark Griswold and Zheng-Rong Lu

Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging

Contrast Media and Molecular Imaging, 2013, 8, 220-8..

119. Xueming Wu, Daniel Lindner, Guan-Ping Yu, and Zheng-Rong Lu

CLT1 Peptide Targeted Small Molecular Contrast Agent for MR Molecular Imaging of Prostate Cancer, JoVE, accepted.

120. Mingqian Tan, Zhen Ye, Daniel Lindner, Susann M. Brady-Kalnay, Zheng-Rong Lu

Synthesis and Evaluation of a Targeted Nanoglobular Dual-Modal Imaging Agent for MR Imaging and Image-Guided Surgery of Prostate Cancer. Pharm. Res. Accepted

121. Susan M. Burden-Gulley, Zhixian Zhou, Sonya E.L. Craig, Zheng-Rong Lu, Susann M. Brady-Kalnay

Molecular Magnetic Resonance Imaging of Tumors with a PTPmu Targeted Contrast Agent, Transl Oncol. 2013 Jun 1;6(3):329-37.

124. Anthony S. Malamas, Maneesh Gujrati, China M. Kummitha, Rongzuo Xu, and Zheng-Rong Lu

Design and Evaluation of New pH-Sensitive Amphiphilic Cationic Lipids for siRNA Delivery. JCR. Accepted.

125. Zhuxian Zhou, Xueming Wu, Adam Kresak, Mark Griswold, Zheng-Rong Lu

Targeting Tumor Microenvironment with Small Peptide Targeted Macrocyclic Gd(III) Chelates For MR Cancer Molecular Imaging. Submitted.

Book Chapters

1. Z.-R. Lu, P. Kopeckova, J. Kopecek

Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for biomedical applications

Polymeric drugs and drug delivery systems, R.M. Ottenbrite, S.W. Kim, Eds.,

Technomics Publishing Co., Lancaster, PA, 1-14, 2000.

2. Z.-R. Lu.

Stability of proteins and nucleic acids.

Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids. R. I. Mahato, Ed., CRC Press, New York, NY, 2005, 352-377.

3. Z.-R. Lu, Y. Wang, F. Ye, A. Vaidya, E.-K. Jeong.

Paramagnetic polymer conjugates for non-invasive evaluation of in vivo drug delivery.

Nanotechnology for Cancer Therapy. M.M. Amiji, Ed. Taylor and Francis Group, LLC, Boca Raton, FL, 2006.

4. Z.-R. Lu.

In Vivo Imaging of Dosage Forms.

A.T. Florence and J. Siepmann, Ed. Modern Pharmaceutics, 5th Edition. Informa Healthcare, New York, NY, 2009.

5. Z.-R. Lu, A. Vaidya.

Image-Guided Photodynamic Cancer Therapy.

Yi Lu and Ram I. Mahato, Ed. Pharmaceutical Perspectives of Cancer Therapeutics. Springer, New York, NY, 2009.

6. Zheng-Rong Lu.

Molecular Imaging of Drug Delivery

Advanced Drug Delivery, John Wiley & Sons, Inc.

Patents.

Biodegradable macromolecular magnetic resonance imaging contrast agents and methods thereof. U.S. Patent No. 6,982,324.

Biodegradable macromolecular magnetic resonance imaging contrast agents and methods thereof. U.S. Patent No. 7,745,590.

Invited symposium lectures

Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]: preparation,

characterization and protein modification, 3rd International Biorelated Polymer. Symposium on Polymeric Drugs and Drug Delivery Systems. ACS, Boston, MA. August 23 – 27, 1998.

Design of novel bioconjugates for targeted drug delivery. 10th International Symposium on Recent Advances in Drug Delivery System. Salt Lake City, Utah. February 19-22, 2001.

A novel biodegradable macromolecular blood pool MRI contrast agent. The XV Annual International Workshop on MRA, Dublin, Ireland, September 24-26, 2003.

Design of biodegradable macromolecular MRI contrast agents. Gordon Conference on Drug Carriers in Medicine and Biology. Big Sky, MT, September 5-10, 2004.

Recent progress on preclinical evaluation of a biodegradable macromolecular MRI contrast agent, (Gd-DTPA)-cystamine copolymers. The XVI Annual International Workshop on Magnetic Resonance Angiography (MRA). London, ON, Canada, October 5-9, 2004.

Poly(L-glutamic acid) Gd-DOTA conjugate with a disulfide spacer as novel blood pool contrast agent. The XV Annual International Workshop on MRA. Beijing, China, September 21-23, 2005.

Contrast enhanced MRA with biodegradable polydisulfide blood pool contrast agents in an animal model. The XV Annual International Workshop on MRA. Basel, Switzerland, September 13-15th, 2006.

Biodegradable macromolecular MRI contrast agents. The Nanomedicine Symposium 2006, Dallas, Texas, December 10, 2006.

Contrast enhanced MRI guided photodynamic therapy. 2006 International Conference on Bio and Pharmaceutical Science and Technology, San Diego, CA, December 18-21, 2006.

Polymer platform for drug delivery and molecular imaging. 13th International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007.

Biodegradable macromolecular MRI contrast agents. 2007 Annual Meeting of the Controlled Release Society. July, 7-11, 2007, Long Beach, CA.

Biodegradable macromolecular MRI contrast agents and their applications. The first Chinese Society of Magnetic Resonance in Medicine (CSMRM) Meeting, August 8-10, 2007, Dalian, China

Non-invasive visualization of in vivo drug delivery and evaluation of therapeutic response with contrast enhanced MRI. Workshop on Molecular Imaging and Drug Delivery, 2007 Annual Meeting of the Controlled Release Society. July, 7-11, 2007, Long Beach, CA.

Nanoglobular MRI contrast agents. The XVI Annual International Workshop on MRA. Istanbul, Turkey, October 3-5, 2007.

Biodegradable macromolecular MRI contrast agents. 2007 Contrast Media Research Symposium. October, 16-20th, 2007, Banff, Canada.

Macromolecules and dendrimers for targeted imaging. 16th Scientific meeting of International Society for Magnetic Resonance in Medicine. May 3-9, 2008, Toronto, Canada.

A systemic targeted siRNA delivery system for cancer therapy. The 6th China-Japan-Korea Foresight Joint Symposium on Gene Delivery and International Symposium on Biomaterials, Sanya City, Hainan, China, November 26 -30, 2008.

Tumor Characterization with Biodegradable Macromolecular MRI Contrast Agents

and Dynamic Contrast Enhanced MRI. CMRMF & OCSMRM Joint Meeting 2008, Shenzhen, China, December 13-15, 2008.

Contrast enhanced MRI in drug development. The Controlled Release Society's 36th Annual Meeting and Exposition in Copenhagen, Denmark, 18 -22 July 2009.

Targeted MRI contrast agents. WACBE World Congress on Bioengineering 2009, Hong Kong, 26 - 29 July 2009.

Multifunctional siRNA delivery systems. ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology (NEMB2010) held Feb. 7-10, 2010 in Houston, TX.

Polymer Platforms for Magnetic Resonance Imaging, Symposium on Biomedical Polymers for Drug Delivery, Honoring Dr. Jindřich Kopeček. March 26-27, 2010, Salt Lake City, Utah

Targeted Multifunctional siRNA delivery systems. Particles 2010:  Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology, 22-25 May 2010, Regal Sun Resort, Lake Buena Vista, Florida. 

Targeting Tumor Microenvironment for Cancer Molecular Imaging, Case Comprehensive Cancer Center Scientific Retreat, July 9-10, 2010, Sawmill Creek Resort, OH.

MR molecular imaging of tumor microenvironment. Third OCSMRM/CSMRM Meeting, August 13-15, 2010, Shanghai, China. 

A targeted contrast agent specific to fibronectin for MR molecular imaging of atherosclerotic plaques. 22nd Annual International Conference on Magnetic Resonance Angiography. October 6 – 9th, 2010,
Seoul, Korea

Magnetic Resonance Imaging of Tumor Microenvironment with Macromolecular Contrast Agents, 2010 NanoMedicine Summit, Oct. 18, 2010, Cleveland, Ohio

Multifunctional siRNA delivery systems. Wuhan International Symposium on Biomaterials, July 3, 2011, Wuhan, China

A peptide targeted MRI contrast agent for molecular imaging of of fibrin-fibronectin complex in tumor stroma. Contrast Media Research 2011. October 30 – November 1, 2011, Galveston, Texas

Biodegradable macromolecular MRI contrast agents with high kinetic stability. Polymers in Medicine. Praque, CzechRepublic, July 1-5, 2012.

Targeting tumor microenvironment for cancer detection and therapeutic efficacy evaluation. The 12th Emerging Information and Technology Conference, Toronto, Ontario, Canada, August 16-17, 2012.

Polymerizable lipid-based multifunctional siRNA delivery systems. Oligonucleotide Delivery: Biology, Engineering & Development. Hernstein, Austria, October 7-11, 2012.

pH-sensitive multifunctional lipid siRNA delivery systems. NanoDDS’12. Atlantic City, New Jersey, December 6-7, 2012.

Other invited lectures

Fall, 2003, Department of Bioengineering, University of Utah

Spring, 2004, Department of Radiology, University of Utah

January 2004, Department of Radiology, University of Pittsburg

May 2004, Faculty of Pharmaceutical Sciences, Setsunan University, Japan

August 2005, Department of Radiology, Northwestern University

September 2005, College of Pharmacy, Shanghai Jiaotong University, China

November 2005, Department of Biomedical Engineering, Cornell University

December 2005, Department of Cardiovascular Medicine, Stanford University

September 2006, Abbott Laboratories, Chicago, IL

October 2006, Department of Chemical Engineering, University of Wyoming

January 2007, Department of Molecular Pharmaceutics, University of North Carolina

November 2007, Department of Chemistry, China Northeastern University

November 2007, Shanghai Roche Pharmaceuticals, Shanghai

January 2008, Department of Biomedical Engineering, Georgia Institute of Technology

January 2008, Department of Biomedical Engineering, Emory University

April 2008, Department of Biomedical Engineering, Case Western Reserve University

August 2008, College of Pharmacy, Rutgers University

December 2008, University of Science and Technology of China, Hefei, China

September, 2009, Lanzhou University

October, 2010, Purdue University

October, 2010, University of Pennsylvania

December, 2010, Cleveland State University

February, 2011, Michigan State University

March, 2011, Biochemistry, Case Western Reserve University

April, 2011, Ohio State University

May, 2011, CCCC seminar, Case Western Reserve University

July, 2011, Wuhan University, China.

July, 2011, Tianjin University, China

July, 2011, Tsinghua University, China

December, 2011, Chemistry, Case Western Reserve University

December, 2011, Pharmacology, Case Western Reserve University

January, 2012, Stanford University

March, 2012, University of Illinois at Chicago

May, 2012, Curtin University, Australia

October, 2012, Hainan Medical University, Haikou, China

October, 2012, Hainan University, Haikou, China

October, 2012, Lanzhou University, Lanzhou, China

October, 2012, Tsinghua University, Beijing, China

December, 2012, Macromolecular Science, Case Western Reserve University

February, 2013, Radiology, Case Western Reserve University

Podium symposium presentations

Biorecognizable surfaces containing polymerizable antibody fragments. Surfaces in Biomaterials 2000 Symposium. Scottsdale, Arizona. August 30 – September 2, 2000

Poly(L-glutamic Acid) Gd(III)-DOTA conjugate with controlled degradation for magnetic resonance imaging. CRS Winter Symposia and 11th International Symposium & Exposition on Recent Advances in Drug Delivery Systems. Salt Lake City, UT. March 3 – 6, 2003.

Contrast Enhanced Tumor MRI with a Biodegradable Macromolecular Gd(III) Complex in Mice. 12th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Kyoto, Japan. May 15-21, 2004.

Antitumor efficacy of anti-VEGF SiRNA complexes with a degradable cationic polymer. 31st Annual Meeting of the Controlled Release Society. Honolulu, Hawaii. June 12-16, 2004.

Comparison of poly(L-glutamic acid)-(Gd-DOTA) conjugates with degradable and non-degradable spacer for magnetic resonance imaging. 13th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Miami, FL. May 7-13, 2005

PEG-g-Poly(GdDTPA-co-L-Cystine) as Novel Biodegradable Macromolecular Contrast Agents for MRI. 32st Annual Meeting of the Controlled Release Society. Miami, Florida. June 18-22, 2005.

Bifunctional poly(L-glutamic acid)-(Gd-DO3A)-Mce6 conjugate for MRI guided photodynamic therapy. 33st Annual Meeting of the Controlled Release Society. Vienna, Austria. July 22-26, 2006.

Characterization of Tumor Angiogenesis with Dynamic Contrast Enhanced MRI and Biodegradable Macromolecular Contrast Agents in Mice. 35th Annual Meeting & Exposition of the Controlled Release Society, New York City, NY, July 12 – 16, 2008,

Systemic targeted siRNA delivery with a multifunctional carrier. The Society For Biomaterials 2008 Translational Biomaterial Research Symposium, Atlanta, GA, September 11 - 13, 2008.

Functionalization of a polymerizable pH-sensitive amphiphilic surfactant for efficient ligand-directed siRNA delivery, the American Association of Pharmaceutical Scientists 2008 Annual Meeting and Exposition, Atlanta, GA, November 17 -21, 2008.

A Peptide Targeted Nanoglobular Contrast Agent for Cancer Molecular Imaging with MRI. World Molecular Imaging Congress, September, 23-26, 2009.

Recent abstracts

1. Z.-R. Lu, P. Kopeckova, J. Kopecek

Polymerizable Fab' antibody fragments

The Proceedings of the 25th International Symposium on Controlled Release of Bioactive Materials. Las Vegas, Nevada. June 21-24, 1998. Proceedings, pp. 788-789

2. Z.-R. Lu, P. Kopeckova, Z. Wu, J. Kopecek

Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]: preparation, characterization and protein modification

3rd International Biorelated Polymer Symposium on Polymeric Drugs and Drug

Delivery Systems, American Chemical Society Fall 1998 Meeting.

Boston, MA. August 23-27, 1998. Polymer Preprints 39 (2), 218-219

3. Z.-R. Lu, S.-Q. Gao, P. Kopeckova, J. Kopecek

Lectin-targeted colon specific HPMA copolymer-cyclosporin conjugates

14th Ann. Meeting of the Am. Assoc. of Pharmaceutical Scientists. New Orleans, Louisiana. November 14-18, 1999. AAPS PharmSci. S-441

4. Z-R. Lu, P. Kopeckova, J. Kopecek

Biorecognizable surfaces containing polymerizable antibody fragments

Proceedings of Surfaces in Biomaterials 2000 Symposium. Scottsdale, Arizona. August 30 – September 2, 2000

5. Y. Kasuya, Z.-R. Lu, P. Kopeckova, T. Minko, S.E. Tabibi, J. Kopecek

Synthesis of HPMA copolymer-aminopropylgeldanamycin conjugate

Proceedings of International Symposium on Tumor Targeted Delivery Systems. Bethesda, Maryland. September 25-27, 2000

6. Z.-R. Lu, J.-G. Shiah, P. Kopeckova, J. Kopecek

Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system

Proceedings of International Symposium on Tumor Targeted Delivery Systems. Bethesda, Maryland. September 25-27, 2000

7. Z.-R. Lu, J.-G. Shiah, P. Kopeckova, J. Kopecek

A targeted polymeric drug delivery system based on polymerizable Fab' for the treatment of human ovarian carcinoma

Ann. Meeting of the Am. Assoc. of Pharmaceutical Scientists. Indianapolis, Indiana. October 29-November 2, 2000. AAPS Pharm Sci. 2, 2 #668, 2000.

8. Z.-R. Lu, J.-G. Shiah, S. Sakuma, P. Kopeckova, J. Kopecek

Design of novel bioconjugates for targeted drug delivery

Abstracts of 10th International Symposium on Recent Advances in Drug Delivery Systems. Salt Lake City, Utah. February 19-22, 2001.

9. S. Sakuma, Z. -R. Lu, P. Kopeckova, J. Kopecek

Design of HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin

The proceedings of 28th International Symposium on Controlled Release of Bioactive Materials. San Diego, California. June 23-27, 2001

10. P. Kopeckova, T. Minko, Z.-R. Lu, J. Kopecek

Bioconjugates for the treatment of cancer

Proceedings of 28th International Symposium on Controlled Release of Bioactive Materials. San Diego, California. June 23-27, 2001

11. Y. Kasuya, Z.-R. Lu, P. kopeckova, S.E. Tabibi, J. Kopecek

Influence of the structure of drug moieties on the efficacy of HPMA copolymer-

geldanamycin derivative conjugates

Proceedings of 28th International Symposium on Controlled Release of Bioactive Materials. San Diego, California. June 23-27, 2001

12. Z.-R. Lu, J.-G. Shiah, P. kopeckova, J. Kopecek

Polymerizable Fab' antibody fragment targeted HPMA copolymer-mesochlorin e6 conjugate: biodistribution and antitumor activity

Proceedings of 28th International Symposium on Controlled Release of Bioactive Materials. San Diego, California. June 23-27, 2001

13. Z.-R. Lu, J.-G. Shiah, P. kopeckova, J. Kopecek

Antitumor activity of polymerizable antibody Fab’ targeted mesochlorin e6 in photodynamic therapy in mice.

Proceeddings of 93rd Annual Meeting of AACR. San Francisco, CA. April 6-10, 2002.

14. Z.-R.Lu, D.L. Parker, K.C.Goodrich

Biodegradable macromolecular Gd(III) complexes as blood pool MRI contrast agents. Abstracts of First Annal Meeting of the Society for Molecular Imaging. Boston, MA. August 24-26, 2002.

15. Z.-R. Lu, X. Wang.

Poly(L-glutamic Acid) Gd(III)-DOTA conjugate with controlled degradation for magnetic resonance imaging.

Abstracts of CRS Winter Symposia and 11th International Symposium & Exposition on Recent Advances in Drug Delivery Systems. Salt Lake City, UT. March 3 – 6, 2003.

16. X. Wang and A. Vaidya, Z.-R. Lu

In vivo Degradation of Gd-DTPA-cystamine Copolymers.

Abstracts of Imaging in 2020. Jackson Hole, Wyoming, September 7-11, 2003.

17. Y. Zong, A. M. Mohs and Z.-R. Lu

Synthesis of Gd(III)-DTPA-Cystine and Gd(III)-DTPA-Cystine Ethyl Ester Copolymers for MRI.

Abstracts of Imaging in 2020. Jackson Hole, Wyoming, September 7-11, 2003.

18. Z.-R. Lu, X. Wang, C. Goodrich, and D. Parker.

A novel biodegradable macromolecular blood pool MRI contrast agent.

Abstracts of 15th Annual Meeting of the International MR Angioclub 2003. Dublin, Ireland, September 24-26, 2003.

19. X. Wang, A. Vaidya, Z.-R. Lu

Pharmacokinetics of Biodegradable Macromolecular Gadolinium (III)-DTPA Complexes as MRI Contrast Agents.

2003 AAPS Annual Meeting and Exposition. Salt Lake City, Utah. October 26-30,2003. AAPS PharmSci. 5 (4), M1047.

20. A. M. Mohs, X. Wang, Y. Zong, K. C. Goodrich, D. L. Parker, Z.-R. Lu

Poly(GdDTPA-L-cystine)-g-PEG: a biodegradable macromolecular agent for blood pool MR imaging.

Proceedings of 12th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Kyoto, Japan. May 15-21, 2004.

21. Y. Zong, X. Wang, K. C. Goodrich, A. M. Mohs, D. L. Parker, Z.-R. Lu

Contrast Enhanced Tumor MRI with a Biodegradable Macromolecular Gd(III) Complex in Mice.

Proceedings of 12th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Kyoto, Japan. May 15-21, 2004.

22. X. Wang, J. Zhou, Y. Zong, K. C. Goodrich, L. Yu, Z.-R. Lu

Antitumor efficacy of anti-VEGF SiRNA complexes with a degradable cationic polymer.

Transactions of 31st Annual Meeting of the Controlled Release Society. Honolulu, Hawaii. June 12-16, 2004

23. Y. Zong, X. Wang, A.M. Mohs, C. Goodrich, Z.-R. Lu.

Biodegradable cystine-(Gd-DTPA) copolymers for MR cancer imaging.

Transactions of 31st Annual Meeting of the Controlled Release Society. Honolulu, Hawaii. June 12-16, 2004

24. X. Wang, S. Van, L. Yu, Z.-R. Lu

Gene delivery to primary cells with degradable cationic polymers.

Transactions of 31st Annual Meeting of the Controlled Release Society. Honolulu, Hawaii. June 12-16, 2004

25. X. Wang, Y. Zong, K. C. Goodrich, D. L. Parker, Z.-R. Lu

MR imaging of tumor response to the treatment with anti-VEGF siRNA.

Abstracts of 3rd Annual Meeting of the Society for Molecular Imaging. September 9-12, 2004.

26. X. Wang, Y. Feng, T. Ke, M. Schabel, D.L. Parker and Z.-R. Lu

Recent progress on preclinical evaluation of a biodegradable macromolecular MRI contrast agent, (Gd-DTPA)-cystamine copolymers.

Abstracts of The XVI Annual International Workshop on MRA. London, On, Canada, October 6-8, 2004.

27. X. Wang, F. Y. Feng, T. Ke, Z.-R. Lu

Pharmacokinetics and excretion of biodegradable macromolecular MRI contrast agents.

2004 AAPS Annual Meeting and Exposition. Baltimore, MD. October, 2004. The AAPS Journal, 6(4) W4051, 2004.

28. T. Ke, Y. Feng, F. Ye, J. Guo, D.L. Parker, Z.-R. Lu

Comparison of poly(L-glutamic acid)-(Gd-DOTA) conjugates with degradable and non-degradable spacer for magnetic resonance imaging.

Proceedings of 13th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Miami, FL. May 7-13, 2005.

29. T.D. Nguyen, P. Spincemaille, A. Vaidya, Z.R. Lu, Y. Wang

Biodegradable intravascular Gd-DTPA cystamine copolymers for contrast enhanced magnetic resonance angiography: initial experience with steady state free precession acquisition in a swine model.

Proceedings of 13th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Miami, FL. May 7-13, 2005.

30. Z.-R. Lu. Y. Zong, A. Mohs, Y. Feng

Polydisulfide based biodegradable macromoecular MRI contrast agents.

Proceedings of 13th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Miami, FL. May 7-13, 2005.

31. A. M. Mohs, Y. Zong, Y. Feng, J. Guo, D. L. Parker, Z.-R. Lu

PEG-g-Poly(GdDTPA-co-L-Cystine) as Novel Biodegradable Macromolecular Contrast Agents for MRI.

Transactions of 32st Annual Meeting of the Controlled Release Society. Miami, Florida. June 18-22, 2005.

32. T. K. Kaneshiro, T. Ke, Y. Feng, J. Guo, Z-R. Lu

Synthesis and In Vivo Study of (Gd-DTPA)-co-(L-Cystine Bisalkylamide) Copolymers As Biodegradable Mcromolecular MRI Contrast Agents

Transactions of 32st Annual Meeting of the Controlled Release Society. Miami, Florida. June 18-22, 2005.

33. A. Vaidya, T. Ke, Y. Feng, J. Guo, Z.-R. Lu

Non-invasive In Vivo Imaging of A Polymeric Drug Conjugate Using Contrast Enhanced MRI Transactions of 32st Annual Meeting of the Controlled Release Society. Miami, Florida. June 18-22, 2005.

34. T. K. Kaneshiro, T. Ke, J. Guo, Z-R. Lu

Gd-DTPA Cystine Bisamide Copolymers as Novel Biodegradable Macromolecular MRI Contrast Agents

Abstracts of 4th Annual Meeting of the Society for Molecular Imaging. Cologne, Germany, September 7-10, 2005

35. T. Ke, Y. Feng, J. Guo, D. L. Parker, Z.-R. Lu

Poly(L-glutamic acid) Gd-DOTA conjugate with a disulfide spacer as novel blood pool contrast agent

Abstracts of The XV Annual International Workshop on MRA. Beijing, China, September 21-23, 2005.

36. A. M. Mohs, Y. Zong, D. L. Parker, Z.-R. Lu

PEG-g-(GDDTPA-co-cystine): Effect of the PEG chain length on in vivo contrast enhancement in MRI.

Abstracts of The XV Annual International Workshop on MRA. Beijing, China, September 21-23, 2005

37. Y. Feng, Y. Zong, T. Ke, and Z.-R. Lu

In vivo evaluation of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers as biodegradable macromolecular MRI contrast agents

2005 AAPS Annual Meeting and Exposition. Nashville, TN. November 6-10, 2005

38. A. Vaidya, T. Ke, Y. Sun, EK Jeong, Z.-R. Lu.

Contrast enhanced MRI guided photodynamic therapy for non-invasive treatment of cancer.

14th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in

Medicine. Seattle, WA. May 6-12, 2006.

39. F. Ye, T. Ke, E.-K. Jeong, X. Wang,A. Vaidya, D.L. Parker, Z.-R. Lu.

Non-invasive visualization of drug delivery polymer drug conjugate. 14th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Seattle, WA. May 6-12, 2006.

40. T. Ke, X. Wang, E.K. Jeong, D.L. Parker, Y. Feng, Z.-R. Lu.

RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DOTA) conjugate for detecting an angiogenesis biomarker (v(3 integrin with MR T1 mapping. 14th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Seattle, WA. May 6-12, 2006.

41. A. Vaidya, Y. Sun, E.K. Jeong, Z.-R. Lu.

Bifunctional poly(L-glutamic acid)-(Gd-DO3A)-Mce6 conjugate for MRI guided photodynamic therapy. 33st Annual Meeting of the Controlled Release Society. Vienna, Austria. July 22-26, 2006.

42. Z.-R. Lu.

Biodegradable macromolecular MRI contrast agents. The Nanomedicine Symposium 2006, Dallas, Texas, December 10, 2006.

43. Z.-R. Lu, A. Vaidya, E.K. Jeong, D.L. Parker.

Contrast enhanced MRI guided photodynamic therapy. 2006 International Conference on Bio and Pharmaceutical Science and Technology, San Diego, CA, December 18-21, 2006.

44. T. Kaneshiro, X. Wang, Z.-R. Lu.

Preparation and investigation of polyamidoamine octaammonium polyhedral oligosilsequixane (PAMAM OA-POSS) globular dendrimers as carriers for gene delivery. Gordon Conference on Drug Carriers in Medicine and Biology. Big Sky, MT, September, 2006.

45. Y. Wang, F. Ye, E.-K. Jeong, Z.-R. Lu

Non-invasive visualization of drug delivery with polymer conjugates using contrast enhanced MRI. 2006 AAPS annual meeting, San Antonio, TX. October 29 – November 2, 2006.

46. Z.-R. Lu.

Polymer platform for drug delivery and molecular imaging. 13th International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007.

47. Y. Zong, E.-K. Jeong, D.L. Parker, Z.-R. Lu,

Structure Effect of Biodegradable Macromolecular MRI Contrast Agents on Tumor MR Imaging in an Animal Tumor Model. . 15th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Berlin, Germany. May 19-25, 2007.

48. Y. Feng, E.-K. Jeong, A.M. Mohs, L. Emerson, Z.-R. Lu

Polydisulfide-Based Biodegradable Macromolecular Contrast Agents for Dynamic Contrast Enhanced MRI: First Experience with Human Prostate Cancer Xenograft. 15th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Berlin, Germany. May 19-25, 2007.

49. X. Liu, Y. Feng, Z.-R. Lu, E.-K. Jeong

Rapid Simultaneous Data Acquisition of T1 and T2 Mapping, Using Multishot EPI and Automated Variations of TR and TE at 3T. 15th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine. Berlin, Germany. May 19-25, 2007.

49. A. Vaidya, Y. Sun, E.K. Jeong, Z.-R. Lu.

A PEGylated polymer-photosensitizer conjugate containing Gd (III) for site-specific MRI-guided photodynamic therapy of cancer. 34th Annual Meeting of the Controlled Release Society. July 7-11, 2007, Long Beach, CA.

50. R. Xu, Z.-R. Lu.

A PAMAM Gd-DO3A Conjugate with a Degradable Disulfide Spacer for Magnetic Resonance Imaging. 34th Annual Meeting of the Controlled Release Society. July 7-11, 2007, Long Beach, CA.

51. Z.-R. Lu.

Biodegradable macromolecular MRI contrast agents. 34th Annual Meeting of the Controlled Release Society. July, 7-11, 2007, Long Beach, CA.

52. X.L. Wang, S. Ramusovic, Z.-R. Lu.

A novel multifunctional and polymerizable gene carrier mediated efficient transfection. 34th Annual Meeting of the Controlled Release Society. July, 7-11, 2007, Long Beach, CA.

53. Z.-R. Lu, Y. Feng, E.-K. Jeong.

Biodegradable macromolecular contrast agents and their applications. The first Chinese Society of Magnetic Resonance in Medicine (CSMRM) Meeting, August 8-10, 2007, Dalian, China

54. F. Ye, E.-K. Jeong, D.L. Parker, Z.-R. Lu

Tumor specific peptide-(Gd-DTPA) as targeted MRI contrast agent. Imaging in 2020. Jackson Hole, Wyoming, September 23-27, 2007.

55. T. Kaneshiro, D.L. Parker, Z.-R. Lu

Nanoglobular Gd(III) chelates as novel MRI contrast agents. Imaging in 2020. Jackson Hole, Wyoming, September 23-27, 2007.

56. T. Kaneshiro, D.L. Parker, Z.-R. Lu

Nanoglobular intravascular MRI contrast agents. Abstracts of The 19th Annual International Workshop on MRA. Istanbul, Turkey, October 3 – 5, 2007.

57. Z.-R. Lu, Y. Zong, Y. Feng.

Biodegradable macromolecular MRI contrast agents. Contrast Media Research. October 16-20, 2007, Banff. Canada.

58. Y. Feng, E.-K. Jeong, D.L. Parker, Z.-R. Lu

Comparison of biodegradable macromolecular MRI contrast agents with Gd-(DTPA-BMA) and albumin-(Gd-DTPA) in tumor characterization with DCE MRI, 16th Scientific meeting of International Society for Magnetic Resonance in Medicine. May 3-9, 2008, Toronto, Canada.

59. T. Kaneshiro, E.-K. Jeong, D.L. Parker, Z.-R. Lu,

Nanoglobular Gd-DO3A conjugates as highly effective MRI contrast agents.

16th Scientific meeting of International Society for Magnetic Resonance in Medicine. May 3-9, 2008, Toronto, Canada.

60. Y. Feng, E.-K. Jeong, Z.-R. Lu

Characterization of Tumor Angiogenesis with Dynamic Contrast Enhanced MRI and Biodegradable Macromolecular Contrast Agents in Mice. 35th Annual Meeting & Exposition of the Controlled Release Society, New York City, NY, July 12 – 16, 2008.

61. Xu-Li Wang, Rongzuo Xu, Thanh Nguyen, and Zheng-Rong Lu

Novel Targeted siRNA Delivery Systems with the Function of pH-Sensitive Amphiphilic Endosomal Escape. 35th Annual Meeting & Exposition of the Controlled Release Society, New York City, NY, July 12 – 16, 2008.

62. Xu-Li Wang, Thanh Nguyen, and Zheng-Rong Lu

The Effect of Nanoparticle Stabilization by Disulfide Linkages on DNA and siRNA Delivery with Novel Multifunctional Carriers with pH-Sensitive Amphiphilicity. 35th Annual Meeting & Exposition of the Controlled Release Society, New York City, NY, July 12 – 16, 2008.

63. Xu-Li Wang, Rongzuo Xu, and Zheng-Rong Lu

Targeted delivery systems for in vivo systemic siRNA delivery. Gordon Research Conference on Drug Carriers In Medicine & Biology to be held 08/24/2008 - 08/29/2008 at Big Sky Resort in Big Sky, MT.

64. Zheng-Rong Lu, Xu-Li Wang and Randy Jensen

Systemic targeted siRNA delivery with a multifunctional carrier. The Society For Biomaterials 2008 Translational Biomaterial Research Symposium, Atlanta, GA, September 11 - 13, 2008.

65. Z.-R. Lu

A systemic targeted siRNA delivery system for cancer therapy. The 6th China-Japan-Korea Foresight Joint Symposium on Gene Delivery and International Symposium on Biomaterials, Sanya City, Hainan, China, November 26 -30, 2008.

66. Z.-R. Lu

Tumor Characterization with Biodegradable Macromolecular MRI Contrast Agents

and Dynamic Contrast Enhanced MRI. CMRMF & OCSMRM Joint Meeting 2008, Shenzhen, China, December 13-15, 2008.

67. Xu-Li Wang, Rongzuo Xu, and Zheng-Rong Lu

Functionalization of a polymerizable pH-sensitive amphiphilic surfactant for efficient ligand-directed siRNA delivery, the American Association of Pharmaceutical Scientists 2008 Annual Meeting and Exposition, Atlanta, GA, November 17 -21, 2008.

68. F. Ye, E.-K. Jeong, D.L. Parker, Z.-R. Lu

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI. The World Molecular Imaging Congress; September 10-13, 2008, Nice, France.

69. Xueming Wu, Rongzuo Xu, Eun-Kee Jeong, and Zheng-Rong Lu

IN VIVO ASSESSMENT OF ANTIANGIOGENIC EFFECT OF AVASTIN IN A MOUSE COLON CANCER MODEL BY DCE-MRI WITH A BIODEGRADABLE MACROMOLECULAR CONTRAST AGENT GDCC. 14th International Symposium on Drug Delivery, March, 2009, Salt Lake City, UT

70. Mingqian Tan,† Xueming, Wu,† Eun-Kee Jeong,‡ Furong Ye,† Zheng-Rong Lu

A FIBRIN-FIBRONECTIN SPECIFIC NANOGLOBULAR CONTRAST ADENT FOR CANCER MOLECULAR IMAGING WITH MRI. 14th International Symposium on Drug Delivery, March, 2009, Salt Lake City, UT.

71. Rongzuo Xu, Xu-Li Wang, Zheng-Rong Lu

Spermine based multifunctional carriers for gene delivery. 14th International Symposium on Drug Delivery, March, 2009, Salt Lake City, UT.

72. Zheng-Rong Lu, Xuli Wang, Rongzuo Xu

In vivo systemic and targeted delivery of a therapeutic siRNA with multifunctional delivery system. The Biology of RNA Silencing (D6). Apr. 25-30, 2009, Victoria, British Columbia, Canada

73. Mingqian Tan, Xueming Wu, Furong Ye, Eun-Kee Jeong, Zheng-Rong Lu

A CLT1 Peptide Targeted Nanoglobular Contrast Agent for Cancer Molecular Imaging with MRI. 17th Scientific meeting of International Society for Magnetic Resonance in Medicine. April 18-24, 2009, Honolulu, HI.

74. Rongzuo Xu, Xue-Ming Wu, Eun-Kee Jeong, Zheng-Rong Lu

Evaluation of Toxicity of Gadolinium Based Contrast Agents on Skin Fibroblasts. 17th Scientific meeting of International Society for Magnetic Resonance in Medicine. April 18-24, 2009, Honolulu, HI.

75. Yi Feng, Eun-Kee Jeong, Lyska Emerson, Zheng-Rong Lu

Application of a Biodegradable Macromolecular Contrast Agent in Dynamic Contrast Enhanced MRI to Assess the Efficacy of Indocyanine Green Enhanced Photothermal Cancer Therapy. 17th Scientific meeting of International Society for Magnetic Resonance in Medicine. April 18-24, 2009, Honolulu, HI.

76. XueMing Wu, Rongzuo Xu, Eun-Kee Jeong, James N. Lee, Zheng-Rong Lu

Assessment of the Antiangiogenic Therapy of Avastin in an Animal Colon Cancer Model with DCE-MRI and a Biodegradable Macromolecular Contrast Agent. 17th Scientific meeting of International Society for Magnetic Resonance in Medicine. April 18-24, 2009, Honolulu, HI.

77. Zheng-Rong Lu.

Contrast Enhanced MRI in Drug Development. CRS 36th Annual Meeting & Exposition, July 18-22, 2009, Copenhagen, Denmark

78. Zheng-Rong Lu and Furong Ye

A Targeted Contrast Agent for MR Molecular Imaging of Cancer. WACBE World Congress on Bioengineering 2009, Hong Kong, July 26 – 29, 2009.

79. Mingqian Tan, Eun-Kee Jeong, Zheng-Rong Lu

A Peptide Targeted Nanoglobular Contrast Agent for Cancer Molecular Imaging with MRI. World Molecular Imaging Congress, September 23-26, 2009.

80. Zhen Ye, Eun-Kee Jeong, Dennis L. Parker, Zheng-Rong Lu

A Manganese Based Biodegradable Macromolecular MRI Contrast Agent for Cardiovascular Imaging. September 29th - October 1st, 2009, Lansing, MI.

81. Zheng-Rong Lu, et al.,

Multifunctional siRNA delivery systems. ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology (NEMB2010) held Feb. 7-10, 2010 in Houston, TX.

82. Zheng-Rong Lu, et al.,

Polymer Platforms for Magnetic Resonance Imaging, Symposium on Biomedical Polymers for Drug Delivery, Honoring Dr. Jindřich Kopeček. March 26-27, 2010, Salt Lake City, Utah

83. D. S. Gao, M. Tan, J. S. Cheung, A. M. Chow, S. J. Fan, K. W. Chan, K. Man, Z-R. Lu, and E. X. Wu

MRI of Liver Fibrosis by Fibrin-Fibronectin Targeted Contrast Agent. Joint Annual Meeting ISMRM-ESMRMB 2010. 1-7 May 2010, Stockholmsmässan AB, Stockholm, Sweden

84. Mingqian Tan, Eun-Kee Jeong, Dennis Parker, Zheng-Rong Lu

A targeted nanoglobular Mn(II) chelate conjugate for MR cancer molecular imaging Joint Annual Meeting ISMRM-ESMRMB 2010. 1-7 May 2010, Stockholmsmässan AB, Stockholm, Sweden

85. Xueming Wu, Zhen Ye, Zheng-Rong Lu

Comparative study of Zinc and Copper transmetallation of Gd-DTPA cystamine copolymers (GDCC), Omniscan, MultiHance and ProHance in Rats. Fourth Annual Symposium on Nephrogenic Systemic Fibrosis and Gadolinium Based Contrast Agent, May 14-15, 2010, New Heaven, CT

86. Zheng-Rong Lu, et al.,

Targeted Multifunctional siRNA delivery systems. Particles 2010:  Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology, 22-25 May 2010, Regal Sun Resort, Lake Buena Vista, Florida. 

87. Zheng-Rong Lu, et al.,

Targeting Tumor Microenvironment for Cancer Molecular Imaging, Case Comprehensive Cancer Center Scientific Retreat, July 9-10, 2010, Sawmill Creek Resort, OH.

88. Mei Zheng, Zheng-Rong Lu

Delivery of siRNA into primary macrophages with a multifunctional non-viral vector. CRS 37th Annual Meeting & Exposition, July 10-14, 2010, Portland, Oregon

89. Zheng-Rong Lu, et al.,

MR molecular imaging of tumor microenvironment. Third OCSMRM/CSMRM Meeting, August 13-15, 2010, Shanghai, China. 

90. Xueming Wu, Zheng-Rong Lu

A targeted contrast agent specific to fibronectin for MR molecular imaging of atherosclerotic plaques. 22nd Annual International Conference on Magnetic Resonance Angiography. October 6 – 9th, 2010,
Seoul, Korea

91. Zheng-Rong Lu

Magnetic Resonance Imaging of Tumor Microenvironment with Macromolecular Contrast Agents, 2010 NanoMedicine Summit, Oct. 18, 2010, Cleveland, Ohio

92. Cheung, Jerry; Chow, April; Fan, Shu; Gao, Darwin; Lu, Zheng-Rong; Man, Kwan; Tan, Mingqian; Wu, Ed

Molecular MRI of Liver Fibrosis by Fibrin-Fibronectin Targeted Contrast Agent in an Experimental Mouse. Joint Annual Meeting ISMRM-ESMRMB 2011. May 7 – 13, 2011, Montreal, Canada.

93. Tan, Mingqian and Lu, Zheng-Rong, Evaluation of a Targeted Nanoglobular Gd Chelate for MRI Molecular Imaging of Prostate Tumor in an Orthotopic Mouse Model. Joint Annual Meeting ISMRM-ESMRMB 2011. May 7 – 13, 2011, Montreal, Canada.

94. Wu, Xueming, Tan, Mingqian; Lu, Zheng-Rong. A Peptide-Targeted MRI Contrast Agent for Cancer Molecular Imaging. Joint Annual Meeting ISMRM-ESMRMB 2011. May 7 – 13, 2011, Montreal, Canada.

95. Z. Ye, X. Wu, M Tan, and Z.-R. Lu. A New Biodegradable MR Contrast Agent with High Kinetic Chelation Stability for Cancer Imaging. Joint Annual Meeting ISMRM-ESMRMB 2011. May 7 – 13, 2011, Montreal, Canada.

96 Wu, Xueming; Ye, Zhen; Tan, Mingqian; Lu, Zheng-Rong. A Peptide-Targeted smal contrast agent for MR molecular imaging. 2011 AAPS Annual Meeting and Exposition. Walter E. Washington Convention Center, Washington, DC, USA, October 23–27, 2011

97. Z.-R. Lu, X. Wu and M. Tan. A peptide targeted MRI contrast agent for molecular imaging of fibrin-fibronectin complex in tumor stroma. Contrast Media Research 2011. October 30 – November 1, 2011, Galveston, Texas

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download